Surabaya, East Java, Indonesia, Nov 14, 2022 – (ACN Newswire via SEAPRWire.com) – The Food and Drug Supervisory Agency (BPOM) has issued emergency use authorization (EUA) for InaVac, a COVID-19 vaccine developed by researchers from Airlangga University (Unair). InaVac, COVID-19 vaccine, is developed by the University of Airlangga in Surabaya, […]

HONG KONG, Sep 23, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), announced the proposed […]

Cambridge, MA, Jul 19, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna’s mRNA COVID-19 vaccine, Spikevax, in a two-dose […]

Cambridge, MA, Feb 17, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna’s mRNA COVID-19 vaccine, Spikevax, in a 50 […]

ADELAIDE, AUS, Aug 26, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints […]

ADELAIDE, AUS, Jul 9, 2021 – (ACN Newswire via SEAPRWire.com) – The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial. Tetherex Pharmaceuticals, Inc. […]